

NCT02322203 Raw comparison:

Summary:
CHIA has 15 criteria while your personal folder has 17 criteria
Total found criteria: 15/15
Total not Found: 0/15
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Males and females who are at least 18 years of age │ Males and females who are at least 18 years of age │
│ at time of enrollment                              │ at time of enrollment                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject understands the investigational nature of  │ Subject understands the investigational nature of  │
│ the study and provides written informed consent    │ the study and provides written informed consent    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects taking any lipid modification therapy     │ Subjects taking any lipid modification therapy     │
│ including but not limited to statins fibrates and  │ including but not limited to statins fibrates and  │
│ bile acid sequestrants                             │ bile acid sequestrants                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects taking fish oil or any other supplements  │ Subjects taking fish oil or any other supplements  │
│ which in the investigator s opinion may interfere  │ which in the investigator s opinion may interfere  │
│ with the study                                     │ with the study                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects with acute liver disease or active peptic │ Subjects with acute liver disease or active peptic │
│ ulcer disease                                      │ ulcer disease                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects with elevated uric acid levels greater    │ Subjects with elevated uric acid levels greater    │
│ than 10 mg/dL or gout                              │ than 10 mg/dL or gout                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnancy or women currently breastfeeding         │ Pregnancy or women currently breastfeeding         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Female subjects taking hormonal contraceptives or  │ Female subjects taking hormonal contraceptives or  │
│ hormone replacement therapy may be included in     │ hormone replacement therapy may be included in     │
│ this study only if they have been on a stable dose │ this study only if they have been on a stable dose │
│ for at least 3 months                              │ for at least 3 months                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ BMI less than 18 5                                 │ BMI less than 18 5                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects with weight that varies greater than 20%  │ Subjects with weight that varies greater than 20%  │
│ over the past 3 months                             │ over the past 3 months                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects taking the following medications for at   │ Subjects taking the following medications for at   │
│ least six weeks which may interfere with the study │ least six weeks which may interfere with the study │
│ will be excluded BAS antibiotics anticoagulants    │ will be excluded BAS antibiotics anticoagulants    │
│ anticonvulsants antiarrhythmic Cyclosporine        │ anticonvulsants antiarrhythmic Cyclosporine        │
│ Mycophenolate and Synthroid Subjects with chronic  │ Mycophenolate and Synthroid Subjects with chronic  │
│ diarrhea gastric bypass or lap band procedures     │ diarrhea gastric bypass or lap band procedures     │
│ ostomies bowel motility problems or other          │ ostomies bowel motility problems or other          │
│ conditions that could affect intestinal fat        │ conditions that could affect intestinal fat        │
│ absorption                                         │ absorption                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects initiating new medications or patients on │ Subjects initiating new medications or patients on │
│ multiple medications may also be excluded          │ multiple medications may also be excluded          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Inability to swallow capsules                      │ Inability to swallow capsules                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a history of type I or type II       │ Patients with a history of type I or type II       │
│ diabetes or HbA1c greater than 6 5%                │ diabetes or HbA1c greater than 6 5%                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Volunteers may also be excluded if in the opinion  │ Volunteers may also be excluded if in the opinion  │
│ of the study investigators they have some other    │ of the study investigators they have some other    │
│ condition or disorder that may adversely affect    │ condition or disorder that may adversely affect    │
│ the outcome of the study or the safety of the      │ the outcome of the study or the safety of the      │
│ volunteer                                          │ volunteer                                          │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 99 Years │
├───────────────────────────────────┤
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛